|
US5552155A
(en)
*
|
1992-12-04 |
1996-09-03 |
The Liposome Company, Inc. |
Fusogenic lipsomes and methods for making and using same
|
|
US5776486A
(en)
|
1993-05-28 |
1998-07-07 |
Aphios Corporation |
Methods and apparatus for making liposomes containing hydrophobic drugs
|
|
US5981501A
(en)
*
|
1995-06-07 |
1999-11-09 |
Inex Pharmaceuticals Corp. |
Methods for encapsulating plasmids in lipid bilayers
|
|
CA2227989A1
(en)
|
1995-08-01 |
1997-02-13 |
Karen Ophelia Hamilton |
Liposomal oligonucleotide compositions
|
|
US6093816A
(en)
|
1996-06-27 |
2000-07-25 |
Isis Pharmaceuticals, Inc. |
Cationic lipids
|
|
US7262173B2
(en)
|
1997-03-21 |
2007-08-28 |
Georgetown University |
Chemosensitizing with liposomes containing oligonucleotides
|
|
AU733310C
(en)
|
1997-05-14 |
2001-11-29 |
University Of British Columbia, The |
High efficiency encapsulation of charged therapeutic agents in lipid vesicles
|
|
US6110745A
(en)
|
1997-07-24 |
2000-08-29 |
Inex Pharmaceuticals Corp. |
Preparation of lipid-nucleic acid particles using a solvent extraction and direct hydration method
|
|
US6410328B1
(en)
|
1998-02-03 |
2002-06-25 |
Protiva Biotherapeutics Inc. |
Sensitizing cells to compounds using lipid-mediated gene and compound delivery
|
|
US6693086B1
(en)
|
1998-06-25 |
2004-02-17 |
National Jewish Medical And Research Center |
Systemic immune activation method using nucleic acid-lipid complexes
|
|
US20030022854A1
(en)
|
1998-06-25 |
2003-01-30 |
Dow Steven W. |
Vaccines using nucleic acid-lipid complexes
|
|
WO2000030444A1
(en)
|
1998-11-25 |
2000-06-02 |
Vanderbilt University |
Cationic liposomes for gene transfer
|
|
AU5905400A
(en)
|
1999-07-14 |
2001-02-05 |
Board Of Regents, The University Of Texas System |
Methods and compositions for delivery and retention of active agents to lymph nodes
|
|
US7094423B1
(en)
|
1999-07-15 |
2006-08-22 |
Inex Pharmaceuticals Corp. |
Methods for preparation of lipid-encapsulated therapeutic agents
|
|
JP4554883B2
(ja)
|
2000-10-04 |
2010-09-29 |
協和発酵キリン株式会社 |
脂質膜による微粒子の被覆方法
|
|
US7713942B2
(en)
|
2001-04-04 |
2010-05-11 |
Nordic Vaccine Technology A/S |
Cage-like microparticle complexes comprising sterols and saponins for delivery of polynucleotides
|
|
WO2002088370A2
(en)
|
2001-04-30 |
2002-11-07 |
Protiva Biotherapeutics Inc. |
Autogene nucleic acids encoding a secretable rna polymerase
|
|
WO2002087541A1
(en)
|
2001-04-30 |
2002-11-07 |
Protiva Biotherapeutics Inc. |
Lipid-based formulations for gene transfer
|
|
EP1441763A2
(en)
|
2001-11-07 |
2004-08-04 |
Inex Pharmaceuticals Corp. |
Mucosal adjuvants comprising an oligonucleotide and a cationic lipid
|
|
EP1519714B1
(en)
|
2002-06-28 |
2010-10-20 |
Protiva Biotherapeutics Inc. |
Method and apparatus for producing liposomes
|
|
CA2532228C
(en)
|
2003-07-16 |
2017-02-14 |
Protiva Biotherapeutics, Inc. |
Lipid encapsulated interfering rna
|
|
EP1664316B1
(en)
*
|
2003-09-15 |
2012-08-29 |
Protiva Biotherapeutics Inc. |
Polyethyleneglycol-modified lipid compounds and uses thereof
|
|
US20050266067A1
(en)
|
2004-03-02 |
2005-12-01 |
Shiladitya Sengupta |
Nanocell drug delivery system
|
|
JP4764426B2
(ja)
|
2004-06-07 |
2011-09-07 |
プロチバ バイオセラピューティクス インコーポレイティッド |
カチオン性脂質および使用方法
|
|
CA2569664C
(en)
|
2004-06-07 |
2013-07-16 |
Protiva Biotherapeutics, Inc. |
Lipid encapsulated interfering rna
|
|
EP1773857A4
(en)
|
2004-07-02 |
2009-05-13 |
Protiva Biotherapeutics Inc |
THE IMMUNE SYSTEM STIMULATING SIRNA MOLECULES AND APPLICATIONS THEREOF
|
|
US20060051405A1
(en)
|
2004-07-19 |
2006-03-09 |
Protiva Biotherapeutics, Inc. |
Compositions for the delivery of therapeutic agents and uses thereof
|
|
CA2587411A1
(en)
|
2004-11-17 |
2006-05-26 |
Protiva Biotherapeutics, Inc. |
Sirna silencing of apolipoprotein b
|
|
JP2006248978A
(ja)
|
2005-03-10 |
2006-09-21 |
Mebiopharm Co Ltd |
新規なリポソーム製剤
|
|
CA2605068A1
(en)
|
2005-04-15 |
2006-10-26 |
The Board Of Regents Of The University Of Texas System |
Delivery of sirna by neutral lipid compositions
|
|
US20080088046A1
(en)
|
2006-10-13 |
2008-04-17 |
Steffen Panzner |
Amphoteric liposomes, a method of formulating an amphoteric liposome and a method of loading an amphoteric liposome
|
|
US20070087045A1
(en)
|
2005-10-14 |
2007-04-19 |
Industrial Technology Research Institute |
Lipid carrier and method of preparing the same
|
|
WO2007048046A2
(en)
|
2005-10-20 |
2007-04-26 |
Protiva Biotherapeutics, Inc. |
Sirna silencing of filovirus gene expression
|
|
CN101346393B
(zh)
|
2005-11-02 |
2015-07-22 |
普洛体维生物治疗公司 |
修饰的siRNA分子及其应用
|
|
US20070218122A1
(en)
|
2005-11-18 |
2007-09-20 |
Protiva Biotherapeutics, Inc. |
siRNA silencing of influenza virus gene expression
|
|
US8598333B2
(en)
|
2006-05-26 |
2013-12-03 |
Alnylam Pharmaceuticals, Inc. |
SiRNA silencing of genes expressed in cancer
|
|
US20080171716A1
(en)
|
2006-08-16 |
2008-07-17 |
Protiva Biotherapeutics, Inc. |
Nucleic acid modulation of toll-like receptor-mediated immune stimulation
|
|
JP5484059B2
(ja)
|
2006-10-06 |
2014-05-07 |
エスシーアイエル テクノロジー ゲゼルシャフト ミット ベシュレンクテル ハフツング |
脊髄核インプラント
|
|
EP2217221B1
(en)
|
2007-10-17 |
2018-06-27 |
Korea Advanced Institute of Science and Technology |
Ldl-like cationic nanoparticles for deliverying nucleic acid gene, method for preparing thereof and method for deliverying nucleic acid gene using the same
|
|
ES2535419T3
(es)
|
2007-12-27 |
2015-05-11 |
Protiva Biotherapeutics Inc. |
Silenciamiento de expresión de quinasa tipo polo usando ARN interferente
|
|
CA2721333C
(en)
|
2008-04-15 |
2020-12-01 |
Protiva Biotherapeutics, Inc. |
Novel lipid formulations for nucleic acid delivery
|
|
US8268796B2
(en)
|
2008-06-27 |
2012-09-18 |
Children's Hospital & Research Center At Oakland |
Lipophilic nucleic acid delivery vehicle and methods of use thereof
|
|
TW201004658A
(en)
|
2008-07-31 |
2010-02-01 |
Enzon Pharmaceuticals Inc |
Nanoparticle compositions for nucleic acids delivery system
|
|
CA2740000C
(en)
|
2008-10-09 |
2017-12-12 |
Tekmira Pharmaceuticals Corporation |
Improved amino lipids and methods for the delivery of nucleic acids
|
|
MX360460B
(es)
|
2008-10-20 |
2018-11-05 |
Alnylam Pharmaceuticals Inc |
Composiciones y metodos para inhibir la expresion de transtiretina.
|
|
CN111808084A
(zh)
|
2008-11-10 |
2020-10-23 |
阿布特斯生物制药公司 |
用于递送治疗剂的新型脂质和组合物
|
|
TW201021853A
(en)
|
2008-11-17 |
2010-06-16 |
Enzon Pharmaceuticals Inc |
Releasable cationic lipids for nucleic acids delivery systems
|
|
US20110305769A1
(en)
|
2008-11-17 |
2011-12-15 |
Enzon Pharmaceuticals, Inc. |
Branched cationic lipids for nucleic acids delivery system
|
|
US10292932B2
(en)
|
2008-12-26 |
2019-05-21 |
Samyang Biopharmaceuticals Corporation |
Polymeric micelle particle comprising anionic drugs and method of preparing the same
|
|
WO2010108934A1
(en)
|
2009-03-25 |
2010-09-30 |
Novartis Ag |
Pharmaceutical composition containing a drug and sirna
|
|
SG10201911942UA
(en)
|
2009-05-05 |
2020-02-27 |
Muthiah Manoharan |
Lipid compositions
|
|
KR101766408B1
(ko)
|
2009-06-10 |
2017-08-10 |
알닐람 파마슈티칼스 인코포레이티드 |
향상된 지질 조성물
|
|
US8569256B2
(en)
|
2009-07-01 |
2013-10-29 |
Protiva Biotherapeutics, Inc. |
Cationic lipids and methods for the delivery of therapeutic agents
|
|
WO2011000107A1
(en)
|
2009-07-01 |
2011-01-06 |
Protiva Biotherapeutics, Inc. |
Novel lipid formulations for delivery of therapeutic agents to solid tumors
|
|
AP2015008874A0
(en)
*
|
2009-08-14 |
2015-11-30 |
Alnylam Pharmaceuticals Inc |
Lipid formulated compositions and methods for inhibiting expression of a gene from the ebola virus
|
|
NZ714887A
(en)
|
2009-09-11 |
2019-07-26 |
Ionis Pharmaceuticals Inc |
Modulation of huntingtin expression
|
|
CN107028886A
(zh)
|
2009-11-04 |
2017-08-11 |
不列颠哥伦比亚大学 |
含有核酸的脂质粒子及相关的方法
|
|
EP3318248B1
(en)
|
2009-12-01 |
2019-04-10 |
Translate Bio, Inc. |
Delivery of mrna for the augmentation of proteins and enzymes in human genetic diseases
|
|
EP2525778B1
(en)
|
2010-01-19 |
2018-08-01 |
Polypid Ltd. |
Sustained-release nucleic acid matrix compositions
|
|
WO2011141704A1
(en)
|
2010-05-12 |
2011-11-17 |
Protiva Biotherapeutics, Inc |
Novel cyclic cationic lipids and methods of use
|
|
KR101198715B1
(ko)
|
2010-05-14 |
2012-11-13 |
한국생명공학연구원 |
핵산 및 친수성 음이온 화합물의 고효율 포획을 위한 비대칭 리포솜 및 이의 제조방법
|
|
US20100239521A1
(en)
|
2010-06-01 |
2010-09-23 |
Mohammad Reza Mozafari |
Method for the preparation of micro- and nano-sized carrier systems for the encapsulation of bioactive substances
|
|
KR20190039347A
(ko)
|
2010-06-03 |
2019-04-10 |
알닐람 파마슈티칼스 인코포레이티드 |
활성제의 전달을 위한 생분해성 지질
|
|
US9006417B2
(en)
|
2010-06-30 |
2015-04-14 |
Protiva Biotherapeutics, Inc. |
Non-liposomal systems for nucleic acid delivery
|
|
SI4043040T1
(sl)
|
2010-08-31 |
2023-04-28 |
Glaxosmithkline Biologicals Sa |
Mali liposomi za dostavo imunogen-kodirajoče RNA
|
|
US8466122B2
(en)
|
2010-09-17 |
2013-06-18 |
Protiva Biotherapeutics, Inc. |
Trialkyl cationic lipids and methods of use thereof
|
|
US9011903B2
(en)
|
2011-06-08 |
2015-04-21 |
Nitto Denko Corporation |
Cationic lipids for therapeutic agent delivery formulations
|
|
RU2013154295A
(ru)
*
|
2011-06-08 |
2015-07-20 |
Шир Хьюман Дженетик Терапис, Инк. |
КОМПОЗИЦИИ ЛИПИДНЫХ НАНОЧАСТИЦ И СПОСОБЫ ДЛЯ ДОСТАВКИ мРНК
|
|
ES2795110T3
(es)
|
2011-06-08 |
2020-11-20 |
Translate Bio Inc |
Lípidos escindibles
|
|
EP2729127B1
(en)
*
|
2011-07-04 |
2018-05-02 |
Statens Serum Institut |
Methods for producing liposomes
|
|
MX366055B
(es)
|
2011-08-31 |
2019-06-26 |
Novartis Ag |
Liposomas pegilados para admistracion de acido ribonucleico (arn) que codifica para inmunogeno.
|
|
US9126966B2
(en)
|
2011-08-31 |
2015-09-08 |
Protiva Biotherapeutics, Inc. |
Cationic lipids and methods of use thereof
|
|
JP2014530602A
(ja)
|
2011-10-05 |
2014-11-20 |
プロティバ バイオセラピューティクス インコーポレイテッド |
アルデヒドデヒドロゲナーゼをサイレンシングするための組成物および方法
|
|
US9579338B2
(en)
|
2011-11-04 |
2017-02-28 |
Nitto Denko Corporation |
Method of producing lipid nanoparticles for drug delivery
|
|
EP3485875A1
(en)
|
2011-11-04 |
2019-05-22 |
Nitto Denko Corporation |
Single use system for sterelily producing lipid-nucleic acid particles
|
|
CA3018046A1
(en)
|
2011-12-16 |
2013-06-20 |
Moderna Therapeutics, Inc. |
Modified nucleoside, nucleotide, and nucleic acid compositions
|
|
EP2817287B1
(en)
|
2012-02-24 |
2018-10-03 |
Arbutus Biopharma Corporation |
Trialkyl cationic lipids and methods of use thereof
|
|
WO2013130824A1
(en)
|
2012-02-29 |
2013-09-06 |
Sangamo Biosciences, Inc. |
Methods and compositions for treating huntington's disease
|
|
BR112014024131A2
(pt)
|
2012-03-29 |
2017-07-25 |
Shire Human Genetic Therapies |
lipídios catiônicos ionizáveis
|
|
WO2013151665A2
(en)
|
2012-04-02 |
2013-10-10 |
modeRNA Therapeutics |
Modified polynucleotides for the production of proteins associated with human disease
|
|
US20160289674A1
(en)
|
2012-04-02 |
2016-10-06 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of membrane proteins
|
|
US9254311B2
(en)
|
2012-04-02 |
2016-02-09 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of proteins
|
|
US10501513B2
(en)
|
2012-04-02 |
2019-12-10 |
Modernatx, Inc. |
Modified polynucleotides for the production of oncology-related proteins and peptides
|
|
EP2858679B2
(en)
|
2012-06-08 |
2024-06-05 |
Translate Bio, Inc. |
Pulmonary delivery of mrna to non-lung target cells
|
|
HRP20181855T1
(hr)
|
2012-06-08 |
2018-12-28 |
Nitto Denko Corporation |
Lipidi za formulacije namijenjene unosu terapijskog sredstva
|
|
BR112015022855A2
(pt)
|
2013-03-14 |
2017-11-07 |
Shire Human Genetic Therapies |
composições e método para produção de um anticorpo in vitro
|
|
EP3750903A1
(en)
|
2013-03-14 |
2020-12-16 |
Translate Bio, Inc. |
Ribonucleic acids with 4'-thio-modified nucleotides and related methods
|
|
EP3388834B1
(en)
|
2013-03-15 |
2020-04-15 |
Translate Bio, Inc. |
Synergistic enhancement of the delivery of nucleic acids via blended formulations
|
|
CN105143456A
(zh)
|
2013-03-15 |
2015-12-09 |
不列颠哥伦比亚大学 |
用于转染的脂质纳米粒子和相关方法
|
|
KR102109188B1
(ko)
|
2013-04-01 |
2020-05-11 |
삼성전자주식회사 |
양이온성 지질을 포함하는 온도민감성 리포좀 및 그의 용도
|
|
EP3019595A4
(en)
*
|
2013-07-09 |
2016-11-30 |
|
THERAPEUTIC USES OF A GENERIC CHANGE WITH CRISPR / CAS SYSTEMS
|
|
JP6620093B2
(ja)
|
2013-07-23 |
2019-12-11 |
アービュートゥス バイオファーマ コーポレイションＡｒｂｕｔｕｓ Ｂｉｏｐｈａｒｍａ Ｃｏｒｐｏｒａｔｉｏｎ |
メッセンジャーｒｎａを送達するための組成物及び方法
|
|
WO2015021465A2
(en)
|
2013-08-09 |
2015-02-12 |
New York University |
Protein engineered systems for delivery of molecules
|
|
ES3032935T3
(en)
|
2013-10-22 |
2025-07-29 |
Translate Bio Inc |
Lipid formulations for delivery of messenger rna
|
|
CN106413811A
(zh)
|
2013-10-22 |
2017-02-15 |
夏尔人类遗传性治疗公司 |
精氨基琥珀酸合成酶缺乏症的mrna疗法
|
|
JP6506749B2
(ja)
|
2013-10-22 |
2019-04-24 |
シャイアー ヒューマン ジェネティック セラピーズ インコーポレイテッド |
フェニルケトン尿症のためのｍＲＮＡ療法
|
|
AU2014340149B2
(en)
*
|
2013-10-22 |
2020-12-24 |
Shire Human Genetic Therapies, Inc. |
CNS delivery of mRNA and uses thereof
|
|
KR102396026B1
(ko)
|
2014-01-21 |
2022-05-09 |
안자리움 바이오사이언시스 아게 |
하이브리도좀, 이를 포함하는 조성물, 이의 제조 방법 및 이의 용도
|
|
ES2745769T3
(es)
|
2014-03-10 |
2020-03-03 |
Editas Medicine Inc |
Procedimientos y composiciones relacionados con CRISPR/CAS para tratar la amaurosis congénita de Leber 10 (LCA10)
|
|
US20170143848A1
(en)
|
2014-03-24 |
2017-05-25 |
Shire Human Genetic Therapies, Inc. |
Mrna therapy for the treatment of ocular diseases
|
|
US9833416B2
(en)
|
2014-04-04 |
2017-12-05 |
Ohio State Innovation Foundation |
Oligonucleotide lipid nanoparticle compositions, methods of making and methods of using the same
|
|
PL4023249T3
(pl)
*
|
2014-04-23 |
2025-03-10 |
Modernatx, Inc. |
Szczepionki z kwasem nukleinowym
|
|
JP6557722B2
(ja)
|
2014-05-30 |
2019-08-07 |
シャイアー ヒューマン ジェネティック セラピーズ インコーポレイテッド |
核酸の送達のための生分解性脂質
|
|
EP3155116A4
(en)
|
2014-06-10 |
2017-12-27 |
Massachusetts Institute Of Technology |
Method for gene editing
|
|
KR102559979B1
(ko)
|
2014-06-24 |
2023-07-25 |
샤이어 휴먼 지네틱 테라피즈 인크. |
핵산의 전달용 입체화학적으로 풍부한 조성물
|
|
EP3160448B1
(en)
|
2014-06-26 |
2025-08-06 |
Ramot at Tel-Aviv University Ltd. |
Liposomal formulations for delivery of nucleic acids
|
|
BR112016030852A2
(pt)
|
2014-07-02 |
2018-01-16 |
Shire Human Genetic Therapies |
encapsulação de rna mensageiro
|
|
JP6767976B2
(ja)
|
2014-12-05 |
2020-10-14 |
トランスレイト バイオ， インコーポレイテッド |
関節疾患の治療のためのメッセンジャーｒｎａ治療法
|
|
JP2018509387A
(ja)
*
|
2015-01-21 |
2018-04-05 |
フェーズアールエックス インコーポレイテッド |
細胞に治療および診断剤を送達するための方法、組成物、ならびにシステム
|
|
EP3247398A4
(en)
|
2015-01-23 |
2018-09-26 |
Moderna Therapeutics, Inc. |
Lipid nanoparticle compositions
|
|
WO2016149508A1
(en)
|
2015-03-19 |
2016-09-22 |
Shire Human Genetic Therapies, Inc. |
Mrna therapy for pompe disease
|
|
EP4667492A3
(en)
|
2015-05-26 |
2026-04-15 |
Ramot at Tel-Aviv University Ltd. |
Targeted lipid particles for systemic delivery of nucleic acid molecules to leukocytes
|
|
US20180200186A1
(en)
|
2015-07-09 |
2018-07-19 |
Insmed Incorporated |
Compositions and methods for treating lung diseases and lung injury
|
|
JP6948313B6
(ja)
|
2015-09-17 |
2022-01-14 |
モデルナティエックス インコーポレイテッド |
治療剤の細胞内送達のための化合物および組成物
|
|
AU2016341309A1
(en)
|
2015-10-22 |
2018-06-07 |
Modernatx, Inc. |
Cancer vaccines
|
|
WO2017070624A1
(en)
|
2015-10-22 |
2017-04-27 |
Modernatx, Inc. |
Tropical disease vaccines
|
|
AU2016342045A1
(en)
|
2015-10-22 |
2018-06-07 |
Modernatx, Inc. |
Human cytomegalovirus vaccine
|
|
EP3368089B1
(en)
|
2015-10-26 |
2025-11-05 |
Translate Bio Ma, Inc. |
Nanoparticle formulations for delivery of nucleic acid complexes
|
|
PL3386484T3
(pl)
|
2015-12-10 |
2022-07-25 |
Modernatx, Inc. |
Kompozycje i sposoby dostarczania środków terapeutycznych
|
|
PT3391875T
(pt)
|
2015-12-18 |
2021-12-20 |
Samyang Holdings Corp |
Método para preparar micelas poliméricas contendo fármaco aniónico
|
|
LT3394030T
(lt)
|
2015-12-22 |
2022-04-11 |
Modernatx, Inc. |
Junginiai ir kompozicijos terapinei medžiagai teikti intraceliuliniu būdu
|
|
CN107281103A
(zh)
|
2016-04-11 |
2017-10-24 |
百奥迈科生物技术有限公司 |
具有高含量阳性脂质化合物的脂质体制剂及其应用
|
|
KR102427379B1
(ko)
|
2016-05-18 |
2022-08-02 |
보이저 테라퓨틱스, 인크. |
헌팅톤 질환을 치료하기 위한 조성물 및 방법
|
|
US20190298657A1
(en)
|
2016-05-18 |
2019-10-03 |
Modernatx, Inc. |
Polynucleotides Encoding Acyl-CoA Dehydrogenase, Very Long-Chain for the Treatment of Very Long-Chain Acyl-CoA Dehydrogenase Deficiency
|
|
EP3469074B1
(en)
|
2016-06-13 |
2020-12-09 |
Translate Bio, Inc. |
Messenger rna therapy for the treatment of ornithine transcarbamylase deficiency
|
|
WO2017218704A1
(en)
|
2016-06-14 |
2017-12-21 |
Modernatx, Inc. |
Stabilized formulations of lipid nanoparticles
|
|
WO2018064755A1
(en)
|
2016-10-03 |
2018-04-12 |
Precision Nanosystems Inc. |
Compositions for transfecting resistant cell types
|
|
EP3528821A4
(en)
|
2016-10-21 |
2020-07-01 |
ModernaTX, Inc. |
HUMAN CYTOMEGALOVIRUS VACCINE
|
|
CA3040337A1
(en)
|
2016-10-26 |
2018-05-03 |
Curevac Ag |
Lipid nanoparticle mrna vaccines
|
|
US11583504B2
(en)
|
2016-11-08 |
2023-02-21 |
Modernatx, Inc. |
Stabilized formulations of lipid nanoparticles
|
|
AU2017356699B2
(en)
|
2016-11-08 |
2021-11-11 |
Ramot At Tel-Aviv University Ltd. |
Cationic lipids for nucleic acid delivery and preparation thereof
|
|
AU2017357758B2
(en)
|
2016-11-10 |
2023-11-16 |
Translate Bio, Inc. |
Improved process of preparing mRNA-loaded lipid nanoparticles
|
|
CA3043033A1
(en)
|
2016-11-10 |
2018-05-17 |
Translate Bio, Inc. |
Improved ice-based lipid nanoparticle formulation for delivery of mrna
|
|
AU2017374042C1
(en)
|
2016-12-09 |
2024-07-11 |
Acuitas Therapeutics, Inc. |
Delivery of target specific nucleases
|
|
US10383952B2
(en)
|
2016-12-21 |
2019-08-20 |
Arcturus Therapeutics, Inc. |
Ionizable cationic lipid for RNA delivery
|
|
CA3055653A1
(en)
|
2017-03-15 |
2018-09-20 |
Modernatx, Inc. |
Lipid nanoparticle formulation
|
|
EP4186888B1
(en)
|
2017-03-15 |
2025-11-26 |
ModernaTX, Inc. |
Compound and compositions for intracellular delivery of therapeutic agents
|
|
WO2018213726A1
(en)
*
|
2017-05-18 |
2018-11-22 |
The Broad Institute, Inc. |
Systems, methods, and compositions for targeted nucleic acid editing
|
|
BR112019025104A2
(pt)
|
2017-05-30 |
2020-06-23 |
Glaxosmithkline Biologicals S.A. |
Método de fabricar um sistema de entrega não viral, sistema de entrega não viral, e, composição
|
|
US20200131498A1
(en)
|
2017-06-14 |
2020-04-30 |
Modernatx, Inc. |
Polynucleotides encoding methylmalonyl-coa mutase
|
|
WO2018232120A1
(en)
|
2017-06-14 |
2018-12-20 |
Modernatx, Inc. |
Compounds and compositions for intracellular delivery of agents
|
|
MA49421A
(fr)
|
2017-06-15 |
2020-04-22 |
Modernatx Inc |
Formulations d'arn
|
|
EP3641834B1
(en)
|
2017-06-19 |
2023-10-04 |
Translate Bio, Inc. |
Messenger rna therapy for the treatment of friedreich's ataxia
|
|
KR20200036873A
(ko)
|
2017-07-14 |
2020-04-07 |
온코루스, 인크. |
캡슐화된 폴리뉴클레오티드 및 사용 방법
|
|
WO2019027055A1
(ja)
|
2017-08-04 |
2019-02-07 |
協和発酵キリン株式会社 |
核酸含有脂質ナノ粒子
|
|
CA3073020A1
(en)
|
2017-08-16 |
2019-02-21 |
Acuitas Therapeutics, Inc. |
Lipids for use in lipid nanoparticle formulations
|
|
EP4501322A3
(en)
|
2017-08-17 |
2025-04-16 |
Acuitas Therapeutics, Inc. |
Lipids for use in lipid nanoparticle formulations
|
|
WO2019036028A1
(en)
|
2017-08-17 |
2019-02-21 |
Acuitas Therapeutics, Inc. |
LIPIDS FOR USE IN LIPID NANOPARTICULAR FORMULATIONS
|
|
EP3675817A1
(en)
|
2017-08-31 |
2020-07-08 |
Modernatx, Inc. |
Methods of making lipid nanoparticles
|
|
WO2019089828A1
(en)
|
2017-10-31 |
2019-05-09 |
Acuitas Therapeutics, Inc. |
Lamellar lipid nanoparticles
|
|
AU2017438994A1
(en)
|
2017-11-09 |
2020-05-28 |
Immunovaccine Technologies Inc. |
Pharmaceutical compositions, methods for preparation comprising sizing of lipid vesicle particles, and uses thereof
|
|
US12036282B2
(en)
|
2017-12-06 |
2024-07-16 |
Newsouth Innovations Pty Limited |
Liposomal system for drug delivery
|
|
US11951210B2
(en)
|
2017-12-12 |
2024-04-09 |
The Johns Hopkins Universty |
Methods for making giant vesicles and their use
|
|
US11167043B2
(en)
|
2017-12-20 |
2021-11-09 |
Translate Bio, Inc. |
Composition and methods for treatment of ornithine transcarbamylase deficiency
|
|
US20210024928A1
(en)
|
2018-02-16 |
2021-01-28 |
Mina Therapeutics Limited |
C/ebp alpha sarna compositions and methods of use
|
|
US20210002640A1
(en)
|
2018-02-28 |
2021-01-07 |
Exicure, Inc. |
Liposomal spherical nucleic acid (sna) constructs for survival of motor neuron (sma) inhibitors
|
|
WO2019191341A1
(en)
|
2018-03-27 |
2019-10-03 |
Factor Bioscience Inc. |
Nucleic acid-based therapeutics
|
|
WO2019191780A1
(en)
|
2018-03-30 |
2019-10-03 |
Arcturus Therapeutics, Inc. |
Lipid particles for nucleic acid delivery
|
|
AU2019254591B2
(en)
|
2018-04-17 |
2025-12-11 |
CureVac SE |
Novel RSV RNA molecules and compositions for vaccination
|
|
US11679159B2
(en)
|
2018-04-29 |
2023-06-20 |
Precision NanoSystems ULC |
Compositions for transfecting resistant cell types
|
|
CN112055695A
(zh)
|
2018-05-01 |
2020-12-08 |
弗莱德哈钦森癌症研究中心 |
用于基因表达的纳米粒子和其用途
|
|
US20210189397A1
(en)
|
2018-05-10 |
2021-06-24 |
Northwestern University |
Self-manageable abnormal scar treatment with spherical nucleic acid (sna) technology
|
|
WO2019226650A1
(en)
|
2018-05-23 |
2019-11-28 |
Modernatx, Inc. |
Delivery of dna
|
|
JP7488193B2
(ja)
|
2018-05-24 |
2024-05-21 |
トランスレイト バイオ， インコーポレイテッド |
チオエステルカチオン性脂質
|
|
EP3823634A4
(en)
|
2018-07-21 |
2022-08-03 |
University of Tennessee Research Foundation |
NEUTRAL LIPOSOMES CONTAINING BIOLOGICAL ACTIVE INGREDIENTS
|
|
JP7422977B2
(ja)
|
2018-07-23 |
2024-01-29 |
トランスレイト バイオ， インコーポレイテッド |
メッセンジャーｒｎａ用乾燥粉末製剤
|
|
WO2020028133A1
(en)
|
2018-07-30 |
2020-02-06 |
Trucode Gene Repair, Inc. |
Lipid nanoparticle formulations comprising nucleic acid mimics
|
|
EP3846857A4
(en)
*
|
2018-09-04 |
2022-10-12 |
The Board Of Regents Of The University Of Texas System |
COMPOSITIONS AND METHODS FOR ORGAN-SPECIFIC DELIVERY OF NUCLEIC ACIDS
|
|
WO2020051243A1
(en)
|
2018-09-04 |
2020-03-12 |
Ohio State Innovation Foundation |
Lipid nanoparticles and methods of using thereof
|
|
EP3849617A1
(en)
|
2018-09-14 |
2021-07-21 |
Translate Bio, Inc. |
Composition and methods for treatment of methylmalonic acidemia
|
|
WO2020061367A1
(en)
|
2018-09-19 |
2020-03-26 |
Modernatx, Inc. |
Compounds and compositions for intracellular delivery of therapeutic agents
|
|
WO2020061457A1
(en)
|
2018-09-20 |
2020-03-26 |
Modernatx, Inc. |
Preparation of lipid nanoparticles and methods of administration thereof
|
|
HRP20240586T1
(hr)
|
2018-10-09 |
2024-07-19 |
The University Of British Columbia |
Sastavi i sustavi koji sadrže transfekcijske sposobne vezikle bez organskih otapala i deterdženta i s njim povezanim postupcima
|
|
EP3876914A2
(en)
|
2018-11-09 |
2021-09-15 |
Translate Bio, Inc. |
Messenger rna therapy for treatment of ocular diseases
|
|
AU2019376006A1
(en)
|
2018-11-09 |
2021-06-03 |
Arbutus Biopharma Corporation |
Cationic lipids containing silicon
|
|
EP3876999A4
(en)
|
2018-11-09 |
2022-08-31 |
Arbutus Biopharma Corporation |
NEGATIVELY CHARGED PEG-LIPID CONJUGATES
|
|
CA3118559A1
(en)
|
2018-11-09 |
2020-05-14 |
Arbutus Biopharma Corporation |
Lipid nanoparticle formulations
|
|
AU2019374871B2
(en)
|
2018-11-09 |
2025-09-11 |
Translate Bio, Inc. |
PEG lipidoid compounds
|
|
CA3119449A1
(en)
|
2018-11-12 |
2020-05-22 |
Translate Bio, Inc. |
Methods for inducing immune tolerance
|
|
JP7667077B2
(ja)
|
2018-11-16 |
2025-04-22 |
日東電工株式会社 |
Ｒｎａ干渉送達製剤及び悪性腫瘍のための方法
|
|
WO2020106946A1
(en)
|
2018-11-21 |
2020-05-28 |
Translate Bio, Inc. |
TREATMENT OF CYSTIC FIBROSIS BY DELIVERY OF NEBULIZED mRNA ENCODING CFTR
|
|
JP2022516318A
(ja)
|
2019-01-04 |
2022-02-25 |
オンコラス， インコーポレイテッド |
カプセル化ポリヌクレオチド及び使用方法
|
|
US12201724B2
(en)
|
2019-01-24 |
2025-01-21 |
CannaClear Inc. |
Lecithin vesicles for oral delivery
|
|
US12502354B2
(en)
|
2019-01-24 |
2025-12-23 |
Northwestern University |
High density lipoprotein mimetic nanoparticles using lipid conjugated core scaffolds
|
|
CN118697900A
(zh)
|
2019-01-31 |
2024-09-27 |
摩登纳特斯有限公司 |
制备脂质纳米颗粒的方法
|
|
AU2020213609B2
(en)
|
2019-01-31 |
2025-08-07 |
Newsouth Innovations Pty Limited |
Liposomal nanoparticle
|
|
SG11202110036RA
(en)
|
2019-03-19 |
2021-10-28 |
Arcturus Therapeutics Inc |
Method of making lipid-encapsulated rna nanoparticles
|
|
JPWO2020189773A1
(https=)
|
2019-03-20 |
2020-09-24 |
|
|
|
KR102732019B1
(ko)
|
2019-04-15 |
2024-11-20 |
글로벌 라이프 사이언시즈 솔루션즈 캐나다 유엘씨 |
T 세포 유전자 발현의 비바이러스 변형
|
|
AU2020268798A1
(en)
|
2019-05-03 |
2021-11-04 |
Dicerna Pharmaceuticals, Inc. |
Double-stranded nucleic acid inhibitor molecules with shortened sense strands
|
|
MA55896A
(fr)
|
2019-05-07 |
2022-03-16 |
Modernatx Inc |
Polynucléotides servant à perturber l'activité de cellule immunitaire et procédés pour les utiliser
|
|
CA3140423A1
(en)
|
2019-05-14 |
2020-11-19 |
Translate Bio, Inc. |
Improved process of preparing mrna-loaded lipid nanoparticles
|
|
EP3982932A4
(en)
|
2019-06-14 |
2023-10-25 |
Particella, Inc. |
COMPOSITIONS AND METHODS FOR BIOLOGICAL RELEASE VEHICLES
|
|
EP3986452A1
(en)
|
2019-06-18 |
2022-04-27 |
CureVac AG |
Rotavirus mrna vaccine
|
|
ES2973521T3
(es)
|
2019-06-20 |
2024-06-20 |
Prec Nanosystems Ulc |
Lípidos ionizables para la administración de ácidos nucleicos
|
|
KR102928289B1
(ko)
|
2019-06-29 |
2026-02-20 |
글로벌 라이프 사이언시즈 솔루션즈 캐나다 유엘씨 |
핵산 전달을 위한 이온화 가능한 지질
|
|
CA3146675A1
(en)
|
2019-07-23 |
2021-01-28 |
Translate Bio, Inc. |
Stable compositions of mrna-loaded lipid nanoparticles and processes of making
|
|
CA3145913A1
(en)
|
2019-07-29 |
2021-02-04 |
James Everett Dahlman |
Nanomaterials containing constrained lipids and uses thereof
|
|
AU2020321021A1
(en)
|
2019-07-30 |
2022-03-10 |
Verndari, Inc. |
Virus-like particle vaccines
|
|
US20220280639A1
(en)
|
2019-07-31 |
2022-09-08 |
Modernatx, Inc. |
Compositions and methods for delivery of rna interference agents to immune cells
|
|
EP4009955A1
(en)
|
2019-08-07 |
2022-06-15 |
ModernaTX, Inc. |
Compositions and methods for enhanced delivery of agents
|
|
CN114901253A
(zh)
|
2019-08-14 |
2022-08-12 |
爱康泰生治疗公司 |
用于递送核酸的改进的脂质纳米颗粒
|
|
CN114502204A
(zh)
|
2019-08-14 |
2022-05-13 |
库尔维科公司 |
具有降低的免疫刺激性质的rna组合和组合物
|
|
EP4021407A1
(en)
|
2019-08-30 |
2022-07-06 |
GlaxoSmithKline Biologicals S.A. |
Jet mixing lipid nanoparticle manufacturing process
|
|
EP4031191A4
(en)
|
2019-09-18 |
2023-10-25 |
The Regents of the University of California |
PROTEIN PRODUCING NANOLIPOSOMES AND USES THEREOF
|
|
AU2020350759A1
(en)
|
2019-09-19 |
2022-03-31 |
Modernatx, Inc. |
Branched tail lipid compounds and compositions for intracellular delivery of therapeutic agents
|
|
KR20240130161A
(ko)
|
2019-10-22 |
2024-08-29 |
제네반트 사이언시즈 게엠베하 |
오르니틴 트랜스카르바밀라제 (otc) 구축물 및 그의 사용 방법
|
|
JP2023502576A
(ja)
|
2019-11-22 |
2023-01-25 |
ジェネレーション バイオ カンパニー |
イオン化可能な脂質およびそれらのナノ粒子組成物
|
|
WO2021108731A1
(en)
|
2019-11-25 |
2021-06-03 |
The Methodist Hospital |
Aposome compositions and methods of use
|
|
EP3838266A1
(en)
|
2019-12-20 |
2021-06-23 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Microfluidic production of biofunctionalized giant unilamellar vesicles for targeted intracellular cargo delivery
|
|
IL294441A
(en)
|
2019-12-31 |
2022-09-01 |
Fred Hutchinson Cancer Center |
Nanoparticle systems to stimulate and maintain immune system responsiveness at treatment sites
|
|
CA3169669A1
(en)
|
2020-01-31 |
2021-08-05 |
Modernatx, Inc. |
Methods of preparing lipid nanoparticles
|
|
EP3858332A1
(en)
|
2020-01-31 |
2021-08-04 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Bottom-up assembly of synthetic extracellular vesicles
|
|
KR20220144416A
(ko)
|
2020-02-04 |
2022-10-26 |
큐어백 아게 |
코로나바이러스 백신
|
|
CN113186203B
(zh)
|
2020-02-13 |
2022-12-30 |
斯微(上海)生物科技股份有限公司 |
治疗或者预防冠状病毒病的疫苗试剂
|
|
CN115427021A
(zh)
|
2020-02-25 |
2022-12-02 |
翻译生物公司 |
制备负载mrna的脂质纳米颗粒的改进方法
|
|
CN113999184B
(zh)
|
2020-02-28 |
2024-11-12 |
深圳深信生物科技有限公司 |
一种胺基脂质化合物、其制备方法和应用
|
|
JP7746280B2
(ja)
|
2020-03-27 |
2025-09-30 |
ジェネレーション バイオ カンパニー |
新規脂質及びそれらのナノ粒子組成物
|
|
CN113456591B
(zh)
|
2020-03-31 |
2022-06-14 |
武汉合生科技有限公司 |
糖基聚醚类化合物脂质体及其制备方法和药物
|
|
US11559577B2
(en)
|
2020-03-31 |
2023-01-24 |
Engimata, Inc. |
Immunogenic composition forming a vaccine, and a method for its manufacture
|
|
WO2021207273A1
(en)
|
2020-04-07 |
2021-10-14 |
The Regents Of The University Of California |
Manufacturing of synthetic exosomes for cns and non-cns delivery of therapeutics
|
|
WO2021207630A1
(en)
|
2020-04-10 |
2021-10-14 |
Northwestern University |
Oxidized tumor cell lysates encapsulated in liposomal spherical nucleic acids as potent cancer immunotherapeutics
|
|
IL297419B2
(en)
|
2020-04-22 |
2025-02-01 |
BioNTech SE |
Coronavirus vaccine
|
|
CA3176844A1
(en)
|
2020-05-01 |
2021-11-04 |
Carlos G. PEREZ-GARCIA |
Nucleic acids and methods of treatment for cystic fibrosis
|
|
EP4146680A1
(en)
|
2020-05-07 |
2023-03-15 |
Translate Bio, Inc. |
Composition and methods for treatment of primary ciliary dyskinesia
|
|
WO2021226468A1
(en)
|
2020-05-07 |
2021-11-11 |
Translate Bio, Inc. |
Improved compositions for cftr mrna therapy
|
|
JP2023526284A
(ja)
|
2020-05-15 |
2023-06-21 |
トランスレイト バイオ， インコーポレイテッド |
ｍＲＮＡ送達のための脂質ナノ粒子製剤
|
|
IL298241A
(en)
|
2020-05-18 |
2023-01-01 |
Generation Bio Co |
New lipids and their nanoparticle preparations
|
|
CN115968278A
(zh)
|
2020-05-18 |
2023-04-14 |
麦氏生物科技有限公司 |
脂质-聚合物组合物及使用方法
|
|
WO2021236855A1
(en)
|
2020-05-19 |
2021-11-25 |
Orna Therapeutics, Inc. |
Circular rna compositions and methods
|
|
US20220049251A1
(en)
|
2020-05-20 |
2022-02-17 |
Nitto Denko Corporation |
dsRNA Directed to Coronavirus Proteins
|
|
CA3170740A1
(en)
|
2020-05-29 |
2021-12-02 |
Curevac Ag |
Nucleic acid based combination vaccines
|
|
CA3180557A1
(en)
|
2020-05-29 |
2021-12-02 |
Lorena Lerner |
Encapsulated rna replicons and methods of use
|
|
EP4175664A2
(en)
|
2020-07-06 |
2023-05-10 |
Janssen Biotech, Inc. |
Prostate neoantigens and their uses
|
|
US20230338288A1
(en)
|
2020-07-14 |
2023-10-26 |
The Research Foundation For The State University Of New York |
Asymmetric charged vesicles and methods of preparing and use thereof
|
|
AU2021307952A1
(en)
|
2020-07-17 |
2023-03-02 |
Generation Bio Co. |
Methods for encapsulating polynucleotides into reduced sizes of Lipid nanoparticles and novel formulation thereof
|
|
GB202011367D0
(en)
|
2020-07-22 |
2020-09-02 |
Micropore Tech Limited |
Method of preparing liposomes
|
|
WO2022020534A1
(en)
|
2020-07-23 |
2022-01-27 |
The Regents Of The University Of California |
Compositions comprising mir-690 and methods therefor
|
|
MA71659A
(fr)
|
2020-08-06 |
2025-05-30 |
Modernatx, Inc. |
Compositions pour l'administration de molécules de charge utile à l'épithélium des voies respiratoires
|
|
EP4192432A1
(en)
|
2020-08-06 |
2023-06-14 |
ModernaTX, Inc. |
Methods of preparing lipid nanoparticles
|
|
US20230338495A1
(en)
|
2020-08-19 |
2023-10-26 |
Vitruviae LLC |
Vaccine Compositions and Antibodies For Lyme Disease
|
|
EP4203987A4
(en)
|
2020-08-25 |
2024-10-16 |
The Regents of The University of California |
COMPOSITIONS AND METHODS FOR THE TREATMENT OF OCULAR NEUROINFLAMMATION
|
|
EP4157344A2
(en)
|
2020-08-31 |
2023-04-05 |
CureVac SE |
Multivalent nucleic acid based coronavirus vaccines
|
|
CA3189903A1
(en)
|
2020-09-11 |
2022-03-17 |
Wilfred Jefferies |
Vaccine for viral pathogens
|